| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035296 |
| Receipt No. | R000040214 |
| Scientific Title | Outcome of post esophageal variceal band ligation with Sucralfate plus Proton pump inhibitor vs. Proton pump inhibitor alone in cirrhotic patients |
| Date of disclosure of the study information | 2018/12/30 |
| Last modified on | 2019/03/17 (Ver. 5) |
| Basic information | ||
| Public title | Outcome of post esophageal variceal band ligation with Sucralfate plus Proton pump inhibitor vs. Proton pump inhibitor alone
in cirrhotic patients |
|
| Acronym | Outcome of post esophageal variceal band ligation with Sucralfate plus Proton pump inhibitor vs. Proton pump inhibitor alone
in cirrhotic patients |
|
| Scientific Title | Outcome of post esophageal variceal band ligation with Sucralfate plus Proton pump inhibitor vs. Proton pump inhibitor alone
in cirrhotic patients |
|
| Scientific Title:Acronym | Outcome of post esophageal variceal band ligation with Sucralfate plus Proton pump inhibitor vs. Proton pump inhibitor alone
in cirrhotic patients |
|
| Region |
|
|
| Condition | |||
| Condition | Portal hyperternsion related UGI bleeding | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the efficacy of proton pump inhibitor plus sucralfate vs proton pump inhibitor alone in EVL ulcers outcome |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To compare the outcomes of variceal band ligations in patients receiving Sucralfate plus PPI vs PPI alone. |
| Key secondary outcomes | 1) To find out the incidence of EVL ulcers in both the groups.
2) To find out the number and mean size of EVL in both the groups within two weeks. 3) To find out the incidence of EVL bleeding or death due to any cause within two weeks of the procedure. 4) To find out the effect of Child-Pugh score and incidence of ulcer formation in both the groups. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | After variceal band ligation, Patient in PPI and sucralfate group will be given Tab Pantoprazole 40 mg twice daily for 14 days along with syrup Sucralfate 10ml four times daily for next two weeks. | ||
| Interventions/Control_2 | After variceal band ligation, patient in PPI will be given only Tab Pantoprazole 40 mg twice daily only for 14 days | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with chronic liver disease who undergo esophageal variceal banding | |||
| Key exclusion criteria | 1. Patients presenting with fundal varices.
2. Patients who had been subjected to injection sclerotherapy sessions or having endoscopically confirmed pre-existing oesophageal ulcers. 3. Patients with co- morbidities like diabetes, bleeding disorders, heart failure, chronic kidney disease and malignancy |
|||
| Target sample size | 58 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Bir Hospital, National Academy of Medical Sciences | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 44600 | ||||||
| Address | Mahabaudhha, Kathmandu, Nepal. | ||||||
| TEL | 009779851152447 | ||||||
| binodkarki@yahoo.com | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Bir Hospital National Academy of Medical sciences | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 44600 | ||||||
| Address | Mahabaudhha, Kathmandu, Nepal. | ||||||
| TEL | 009779851152447 | ||||||
| Homepage URL | http://www.nams.org.np | ||||||
| binodkarki@yahoo.com | |||||||
| Sponsor | |
| Institute | Bir Hospital National Academy of Medical sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Bir Hospital National Academy of Medical science |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | Nepalese |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Academy of Medical Sciences |
| Address | Bir Hospital, Mahabaudhha, Kathmandu |
| Tel | +977-1-4230710 |
| admin@nams.org.np | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 58 | ||||||
| Results | Post EBL ulcer formation is universal phenomenon and using additional sucralfate in a patient who is already taking PPI may not be more effective in reducing the number and size of ulcers and just add to the cost of therapy. Low albumin is the predictor of multiple ulcer formation after esophageal band ligation. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | None |
||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040214 |